Ipilimumab/programmed-cell-death-1-receptor-antagonistsImmune-related pneumonitis: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1789卷 / 1期
关键词：
D O I：
10.1007/s40278-020-74502-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：152 / 152
相关论文
共 50 条
  • [31] Ipilimumab/nivolumabImmune-mediated granulomatous pneumonitis: case report
    Reactions Weekly, 2020, 1808 (1) : 158 - 158
  • [32] Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer
    Khunger, Monica
    Rakshit, Sagar
    Pasupuleti, Vinay
    Hernandez, Adrian V.
    Mazzone, Peter
    Stevenson, James
    Pennell, Nathan A.
    Velcheti, Vamsidhar
    CHEST, 2017, 152 (02) : 271 - 281
  • [33] Ipilimumab/nivolumab/pembrolizumabInterstitial pneumonitis, hepatitis and colitis: case report
    Reactions Weekly, 2018, 1712 (1) : 314 - 314
  • [34] Ipilimumab/nivolumabProgressing bilateral weakness, paraesthesia and pneumonitis: case report
    Reactions Weekly, 2023, 1964 (1) : 241 - 241
  • [35] Recurrent Pneumonitis Induced by Atezolizumab (Anti-Programmed Death Ligand 1) in NSCLC Patients Who Previously Experienced Anti-Programmed Death 1 Immunotherapy-Related Pneumonitis
    Hsu, Ping-Chih
    Li, Shih-Hong
    Yang, Cheng-Ta
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) : E227 - E230
  • [36] Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
    Naidoo, Jarushka
    Wang, Xuan
    Woo, Kaitlin M.
    Iyriboz, Tunc
    Halpenny, Darragh
    Cunningham, Jane
    Chaft, Jamie E.
    Segal, Neil H.
    Callahan, Margaret K.
    Lesokhin, Alexander M.
    Rosenberg, Jonathan
    Voss, Martin H.
    Rudin, Charles M.
    Rizvi, Hira
    Hou, Xue
    Rodriguez, Katherine
    Albano, Melanie
    Gordon, Ruth-Ann
    Leduc, Charles
    Rekhtman, Natasha
    Harris, Bianca
    Menzies, Alexander M.
    Guminski, Alexander D.
    Carlino, Matteo S.
    Kong, Benjamin Y.
    Wolchok, Jedd D.
    Postow, Michael A.
    Long, Georgina V.
    Hellmann, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 709 - +
  • [37] Pneumonitis and pneumonitis-related death in cancer patients treated with programmed cell death-I inhibitors: a systematic review and meta-analysis
    Cui, Peng-Fei
    Ma, Jun-Xun
    Wang, Fei-Xue
    Zhang, Jing
    Tao, Hai-Tao
    Hu, Yi
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 1259 - 1271
  • [38] Lenvatinib/Programmed-cell-death-1-receptor-antagonistsHypothyroidism
    Reactions Weekly, 2024, 2008 (1) : 187 - 187
  • [39] Structure and Interactions of the Human Programmed Cell Death 1 Receptor
    Cheng, Xiaoxiao
    Veverka, Vaclav
    Radhakrishnan, Anand
    Waters, Lorna C.
    Muskett, Frederick W.
    Morgan, Sara H.
    Huo, Jiandong
    Yu, Chao
    Evans, Edward J.
    Leslie, Alasdair J.
    Griffiths, Meryn
    Stubberfield, Colin
    Griffin, Robert
    Henry, Alistair J.
    Jansson, Andreas
    Ladbury, John E.
    Ikemizu, Shinji
    Carr, Mark D.
    Davis, Simon J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (17) : 11771 - 11785
  • [40] The Role of Programmed Cell Death Receptor 1 in Lung Cancer
    Badiu, Dumitru Cristinel
    Zgura, Anca
    Mehedintu, Claudia
    Haineala, Bogdan
    Anghel, Rodica
    Bacinschi, Xenia
    IN VIVO, 2022, 36 (02): : 1007 - 1012
12345